Quantum Biopharma’s 2024 Financial Statements Show Strong Improvements in Cash, Working Capital, Operating Efficiency and the Removal of Material Uncertainty Related to Going Concern
Provided By GlobeNewswire
Last update: Mar 28, 2025
TORONTO, March 28, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), has reported its financial and operational results for the fourth quarter and year ended December 31, 2024.
Read more at globenewswire.comNASDAQ:QNTM (6/3/2025, 9:51:04 AM)
15.39
+0.19 (+1.25%)
Find more stocks in the Stock Screener
QNTM Latest News and Analysis
15 days ago - ChartmillThese stocks are moving in today's pre-market sessionWondering what's happening in Monday's pre-market session? Find an overview in this article.
